Men's Health Men’s Health Medications

This category covers medicines for an enlarged prostate and for male-pattern hair loss, two common concerns that share some of the same treatments.

Medicines in the Men's Health category

Propecia

Finasteride

1 · 5mg

Indicated to manage male pattern hair loss, formulated to target hormonal conversion and support follicle retention.

From $0.60 / tablet View

Rogaine

Minoxidil

5 · 10%

Developed to support hair regrowth to address hair thinning.

From $28.05 / bottle View

Avodart

Dutasteride

0.5mg

Developed to alleviate symptoms of prostate enlargement, indicated to target hormone-related hair loss and support prostate function relief.

From $0.92 / tablet View

Flomax

Tamsulosin

0.2 · 0.4mg

Utilized to relieve urinary symptoms of benign prostatic hyperplasia, intended to support improved flow by relaxing smooth muscle in the prostate.

From $0.74 / tablet View

Finpecia

Finasteride

1mg

Utilized to target male pattern hair loss to support hair regrowth.

From $0.67 / tablet View

Dutas

Dutasteride

0.5mg

Developed to alleviate symptoms of prostatic enlargement and to target androgen-dependent hormone changes.

From $3.15 / tablet View

Hytrin

Terazosin

1 · 2 · 5mg

Formulated to alleviate symptoms of enlarged prostate to support urinary flow.

From $0.98 / tablet View

Uroxatral

Alfuzosin

10mg

The active ingredient is developed to alleviate urinary symptoms associated with benign prostatic hyperplasia and is intended to support improved bladder function.

From $1.39 / tablet View

Jalyn

Dutasteride, Tamsulosin

0.4/0.5mg

Developed to alleviate benign prostatic hyperplasia symptoms to support urinary flow.

From $3.23 / tablet View

Loniten

Minoxidil

5 · 10mg

Utilized to target high blood pressure and promote scalp hair growth.

From $2.98 / tablet View

What’s in this category

Conditions it covers

These medicines are used for benign prostatic hyperplasia and androgenetic alopecia.

Men’s Health in Asia

Enlarged prostate and hair loss are common concerns for men as they age across Asia, and discreet access to treatment has grown across Singapore, Hong Kong and the wider region. Affordable generics have made long-term treatment far more reachable than the original brands.